
Learning Center
INS webinars deliver the most current infusion-related topics in a 60-minute presenter-led session. Each webinar is delivered live and then archived for on-demand viewing. All webinars are free to INS members.
Webinars
- Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/17/2024 at 1:00 AM (EST)
Smart infusion pumps have been around for over 20 years and represent one of the most valuable pieces of health care technology in place to promote patient safety. By allowing significant control over how intravenous medications are administered, errors can be prevented prior to them reaching the patient. A good catch is when smart infusion pump programming triggers an alert for a value that is considered unsafe and temporarily stops additional forward programming of the smart infusion pump. In this session, we will review examples of good catches, discuss how health care systems can quantify cost savings from severe harms averted, and explain how to champion smart pumps as a key tool to safely administer intravenous medications.
Smart infusion pumps have been around for over 20 years and represent one of the most valuable pieces of health care technology in place to promote patient safety. By allowing significant control over how intravenous medications are administered, errors can be prevented prior to them reaching the patient. A good catch is when smart infusion pump programming triggers an alert for a value that is considered unsafe and temporarily stops additional forward programming of the smart infusion pump. In this session, we will review examples of good catches, discuss how health care systems can quantify cost savings from severe harms averted, and explain how to champion smart pumps as a key tool to safely administer intravenous medications.
Learning Objectives: At the conclusion of this session, learners will be able to:
1. Discuss literature on the use of smart infusion pumps and Dose Error Reduction Software (DERS).
2. Define a good catch.
3. Describe how good catch data can be used to promote the use of smart infusion pumps to improve patient safety.
Joanne Hatfield, PharmD, BCPS
Joanne Hatfield, PharmD, BCPS, is the director of clinical solutions at Bainbridge Health, where she leads the analysis and interpretation of network data in order to provide actionable insights to improve medication safety. Dr. Hatfield also coordinates and provides educational activities for the National Infusion Collaborative, the largest collective of infusion practitioners across the United States. She previously served as clinical manager and cochair of the Pharmacy and Therapeutics Committee at University Health-Truman Medical Centers, where she was responsible for complete formulary oversight and clinical operations. Dr. Hatfield is board certified in pharmacotherapy and completed the ASHP Foundation Traineeship in Pain and Palliative Care.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: January 17, 2027
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
- Contains 3 Component(s), Includes Credits Recorded On: 11/15/2023
Come learn how to handle the pitfalls in infusion nursing delivery. In this session, we will review the legal challenges with infusion nursing liability and offer reduction strategies. You will gain the tools you need in today’s lawsuit-prone health care system so you can protect one of your greatest assets—your nursing license. This is vital information for every infusion nurse.
Come learn how to handle the pitfalls in infusion nursing delivery. In this session, we will review the legal challenges with infusion nursing liability and offer reduction strategies. You will gain the tools you need in today’s lawsuit-prone health care system so you can protect one of your greatest assets—your nursing license. This is vital information for every infusion nurse.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe nursing negligence and malpractice and how it affects your everyday nursing practice.
• Discuss two strategies to reduce your liability exposure.
• Explain the four elements of nursing malpractice lawsuits that must be proven at trial.Elizabeth Rudolph, JD, MSN, RN, PLNC
Elizabeth Rudolph, JD, MSN, RN, PLNC, is an attorney and nurse with many years of experience practicing health care law in Memphis, Tennessee. She obtained her Bachelor’s in Nursing, Master’s in Nursing, and law degree from Vanderbilt University in Nashville, Tennessee.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: November 15, 2026
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
- Contains 3 Component(s), Includes Credits Recorded On: 10/02/2023
Thyroid eye disease (TED) is a serious, progressive autoimmune disease with a limited window for pharmacologic treatment during the active disease. During this window, the disease may respond to pharmacologic intervention. During this webinar, we will discuss the progression of thyroid eye disease, as well as the symptoms, causes, management, and treatment modalities.
Thyroid eye disease (TED) is a serious, progressive autoimmune disease with a limited window for pharmacologic treatment during the active disease. During this window, the disease may respond to pharmacologic intervention. During this webinar, we will discuss the progression of thyroid eye disease, as well as the symptoms, causes, management, and treatment modalities.
Learning Outcome: At the conclusion of this webinar, learners will be able to:
1. Describe the causes of TED as well as the symptomatology and the progression of the disease.
2. Discuss management and treatment options available for patients with this condition.Dr. Alon Kahana, MD, PhD
Dr. Alon Kahana, MD, PhD, is an oculoplastic and orbital surgeon in Michigan, and founder of Kahana Oculoplastic and Orbital Surgery PLLC. Dr. Kahana serves as a professor of ophthalmology and vice chair for academic affairs at Oakland University William Beaumont School of Medicine. Following graduation from Brandeis University, he earned an MD and a PhD in molecular genetics and cell biology at The University of Chicago Pritzker School of Medicine. This education was followed by a residency in ophthalmology and a fellowship in oculofacial plastic and reconstructive surgery at the University of Wisconsin, Madison. Dr. Kahana served on the faculty of the University of Michigan Kellogg Eye Center, rising to the rank of associate professor with tenure. He left the University of Michigan in 2020 to start his own practice. Dr. Kahana’s research interests include tissue repair and regeneration, thyroid eye disease, cancer stem cells, and surgical outcomes. He has received numerous grants and awards, and serves as the president of the North American Society of Academic Orbital Surgeons.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: October 2, 2026
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
- Contains 3 Component(s), Includes Credits Recorded On: 09/12/2023
Although infusion of fluids and medications is traditionally performed intravenously, venous depletion in patients has led to the quest for vessel health preservation. A safe, effective, acceptable, and efficient alternative is the subcutaneous route. However, a lack of organizational policies may contribute to the slow uptake of this practice. An international, interprofessional consensus panel adopted a modified e-Delphi approach to develop practice recommendations for subcutaneous infusion therapy. In this session, you will learn how you can safely administer subcutaneous infusion therapy and help preserve your patients’ veins.
Although infusion of fluids and medications is traditionally performed intravenously, venous depletion in patients has led to the quest for vessel health preservation. A safe, effective, acceptable, and efficient alternative is the subcutaneous route. However, a lack of organizational policies may contribute to the slow uptake of this practice. An international, interprofessional consensus panel adopted a modified e-Delphi approach to develop practice recommendations for subcutaneous infusion therapy. In this session, you will learn how you can safely administer subcutaneous infusion therapy and help preserve your patients’ veins.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe indications/contraindications and risks/benefits of subcutaneous infusions.
• Explain site assessment, device placement, and monitoring of subcutaneous infusions.
• Identify strategies to support competency and quality.Daphne Broadhurst, RN, MN, CVAA(c)
Daphne Broadhurst is the director of clinical infusion services for Nipro Canada. She is proud to be a former adjunct research fellow with Griffith University, Australia and a past president of the Canadian Vascular Access Association. She is a costeering lead and coauthor of the 2024 Canadian Vascular Access and Infusion Therapy Guidelines and a coauthor of the International 2021 INS Standards of Infusion Therapy. She is published in 15 journals and has presented vascular access and infusion therapy best practices globally.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: September 12, 2026
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
- Contains 3 Component(s), Includes Credits Recorded On: 08/23/2023
Over the last decade, infusion nurses have been increasingly challenged by patients presenting with difficult vascular access, which is often the result of age, comorbidities, or damage from previous failed vascular access devices. Selecting and inserting the right device to meet patients’ clinical needs has become more difficult, and has been worsened by complex organizational factors. Peripheral intravenous catheters (PIVCs) and peripherally inserted central catheters (PICC) continue to be the default devices chosen for short-to-moderate term peripherally compatible intravenous treatments. Although midline catheters (MCs) offer an alternate option, the uptake of this device has been limited due to a lack of clinical data supporting their use. This presentation will provide an overview of recent research involving MCs. It will include a summary of international guidelines and share the results from two recent randomised controlled trials (MCs vs PIVCs; MCs vs PICCs) conducted in Brisbane, Australia.
Over the last decade, infusion nurses have been increasingly challenged by patients presenting with difficult vascular access, which is often the result of age, comorbidities, or damage from previous failed vascular access devices. Selecting and inserting the right device to meet patients’ clinical needs has become more difficult, and has been worsened by complex organizational factors. Peripheral intravenous catheters (PIVCs) and peripherally inserted central catheters (PICC) continue to be the default devices chosen for short-to-moderate term peripherally compatible intravenous treatments. Although midline catheters (MCs) offer an alternate option, the uptake of this device has been limited due to a lack of clinical data supporting their use. This presentation will provide an overview of recent research involving MCs. It will include a summary of international guidelines and share the results from two recent randomised controlled trials (MCs vs PIVCs; MCs vs PICCs) conducted in Brisbane, Australia.
Learning Objectives: At the conclusion of this session, learners will be able to:
- Explain the complications associated with PIVCs, MCs, and PICCs.
- Understand the different types of MCs available and how they meet clinical and organizational needs.
- Describe the importance of MC surveillance.
- Discuss the barriers faced by health care organizations introducing MCs.
Dr Nicole Marsh, PhD, MAdvPrac, BN
Dr. Nicole Marsh is the nursing and midwifery director of research at the Royal Brisbane and Women’s Hospital, the largest health service in Australia. Her program of research, which is underpinned by more than 100 publications, focuses on improving patient outcomes and decreasing complications associated with vascular access across the acute clinical care and community setting. She has recently quantified the international incidence of peripheral intravenous catheter failure and identified risk factors associated with this failure, and is currently leading a team who is investigating the clinical and economic benefit of different workforce models for vascular access device insertion to improve patient outcomes. In recognition of her expertise, Dr. Marsh was invited to advise on the development of the Australian Commission on Safety and Quality in Healthcare’s 2021 Peripheral Intravenous Catheter Clinical Care Standard, which all Australian hospitals are expected to use to support and monitor their clinical practice.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: August 23, 2026
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
Access Date | Quiz Result | Score | Actions |
---|